Literature DB >> 16932075

Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products.

Davide Seripa1, Emanuela Signori, Carolina Gravina, Maria Giovanna Matera, Monica Rinaldi, Vito M Fazio.   

Abstract

Several protein and DNA-based methods have been previously described for the identification of apolipoprotein E isoforms or genotypes. However, all of them generate frequently false-positive results. The purpose of this study was to set up a new, simple, and effective method for the analysis of the apoE polymorphism. A total of 1,253 subjects previously examined for the apolipoprotein E polymorphism by restriction fragment length polymorphism were reanalyzed by our new method based on Taq DNA polymerase's inability to correctly initiate the replication in the presence of a mismatch at the 3' end of the primer. We conceived a combination of 4 specific primers in 3 different pairs sharing the same stringent polymerase chain reaction conditions to directly detect the presence/absence of polymerase chain reaction products, and thus reveal the 6 apolipoprotein E genotypes. We confirm our previous results in 1,171 subjects, whereas in 82 subjects out of 1,253 (about 6%), the results have been reinterpreted. The final analysis revealed a total of 12 homozygotic subjects for the e2 allele (1.0%), 874 homozygotes for the e3 allele (69.8 %), and 8 homozygotes for the e4 allele (0.6 %). The frequence of heterozygotes was 8.7% for the e2/e3 genotype (n=109), 1.4% for the e2/e4 genotype (n=17), and 0.6% for the e3/e4 genotype (n=8). Relative allele frequencies were e2=0.060, e3=0.834, and e4=0.106. We describe a new, simple, unequivocal, and nonexpensive method for the identification of the 6 apoE genotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932075     DOI: 10.1097/01.pdm.0000213451.99655.1d

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  13 in total

1.  Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.

Authors:  Maria G Matera; Daniele Sancarlo; Francesco Panza; Carolina Gravina; Grazia D'Onofrio; Vincenza Frisardi; Grazia Longo; Luigi P D'Ambrosio; Filomena Addante; Massimiliano Copetti; Vincenzo Solfrizzi; Davide Seripa; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-04-20

2.  Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease.

Authors:  Davide Seripa; Francesco Panza; Giulia Paroni; Grazia D'Onofrio; Paola Bisceglia; Carolina Gravina; Maria Urbano; Madia Lozupone; Vincenzo Solfrizzi; Alessandra Bizzarro; Virginia Boccardi; Chiara Piccininni; Antonio Daniele; Giancarlo Logroscino; Patrizia Mecocci; Carlo Masullo; Antonio Greco
Journal:  Mol Neurobiol       Date:  2017-06-19       Impact factor: 5.590

3.  Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study.

Authors:  Paroni Giulia; Lauriola Michele; Fontana Andrea; D'Onofrio Grazia; Ciccone Filomena; Paris Francesco; Cascavilla Leandro; Urbano Maria; Gravina Carolina; Copetti Massimiliano; Greco Antonio
Journal:  Aging Dis       Date:  2015-11-24       Impact factor: 6.745

4.  Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.

Authors:  Alberto Pilotto; M Franceschi; G D'Onofrio; A Bizzarro; F Mangialasche; L Cascavilla; F Paris; M G Matera; Andrea Pilotto; A Daniele; P Mecocci; C Masullo; B Dallapiccola; D Seripa
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

5.  Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients.

Authors:  Filomena Addante; Daniele Sancarlo; Massimiliano Copetti; Carlo Scarcelli; Maria Grazia Longo; Valeria Niro; Giulia Paroni; Fabio Pellegrini; Luigi Fontana; Alberto Pilotto
Journal:  Rejuvenation Res       Date:  2011-04       Impact factor: 4.663

6.  A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease.

Authors:  Emma De Feo; Consuelo Cefalo; Dario Arzani; Rosarita Amore; Raffaele Landolfi; Antonio Grieco; Walter Ricciardi; Luca Miele; Stefania Boccia
Journal:  Mol Biol Rep       Date:  2012-02-15       Impact factor: 2.316

7.  The complex interaction between APOE promoter and AD: an Italian case-control study.

Authors:  Alessandra Bizzarro; Davide Seripa; Adele Acciarri; Maria Giovanna Matera; Alberto Pilotto; Francesco Danilo Tiziano; Christina Brahe; Carlo Masullo
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

8.  Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients.

Authors:  Alberto Pilotto; Maria G Matera; Luigi Ferrucci; Daniele Sancarlo; Gioacchino Leandro; Grazia D'Onofrio; Davide Seripa; Filomena Addante; Marilisa Franceschi; Bruno Dallapiccola
Journal:  Rejuvenation Res       Date:  2009-08       Impact factor: 4.663

9.  FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease.

Authors:  Giulia Paroni; Davide Seripa; Andrea Fontana; Grazia D'Onofrio; Carolina Gravina; Maria Urbano; Leandro Cascavilla; Fabio Pellegrini; Antonio Greco; Alberto Pilotto
Journal:  Clin Interv Aging       Date:  2014-10-21       Impact factor: 4.458

10.  A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression.

Authors:  Emma De Feo; Benedetto Simone; Roberto Persiani; Ferdinando Cananzi; Alberto Biondi; Dario Arzani; Rosarita Amore; Domenico D'Ugo; Gualtiero Ricciardi; Stefania Boccia
Journal:  BMC Cancer       Date:  2012-10-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.